StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$105.88+0.28 (+0.27%)

Close on Nov 17, 2026Market cap $4.73BP/E –Yield –

Grail total assets

Total assets on the balance sheet at the end of each period.

Grail's total assets was $2.84B at Jun 30, 2026. For fiscal 2025 it was $2.92B, down 2.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.92B-2.1%
FY2024Dec 31, 2024$2.98B-23.8%
FY2023Dec 31, 2023$3.91B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.84B+5.2%
Q1 FY2026Mar 31, 2026$2.80B-1.5%
Q4 FY2025Dec 31, 2025$2.92B-2.1%
Q3 FY2025Sep 30, 2025$2.60B-16.6%
Q2 FY2025Jun 30, 2025$2.70B-17.3%
Q1 FY2025Mar 31, 2025$2.85B-27.2%
Q4 FY2024Dec 31, 2024$2.98B–
Q3 FY2024Sep 30, 2024$3.12B–
Q2 FY2024Jun 30, 2024$3.27B–
Q4 FY2023Dec 31, 2023$3.91B–

More Grail figures

See a number that looks wrong?